Yoderm
AcquiredOakland, United States · Founded 2012 · $6.0M raised
- Headquarters
- Oakland, California
- Founded
- 2012
- Website
- yoderm.com
- Total Funding
- $6.0M
- Last Round
- $6.0M SeedDec 2019
- Rounds
- 1
About
Yoderm (later rebranded as Apostrophe) was a teledermatology platform connecting patients with board-certified dermatologists for personalized skincare treatments including acne, rosacea, and hyperpigmentation. Founded in 2012 and rebranded to Apostrophe in 2017, it was acquired by Hims & Hers Health in 2021 for $190 million and shut down in March 2025.
Summary
Yoderm is a Healthcare company based in Oakland, United States, founded in 2012. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Dec 2019. Investors include Hims & Hers Health Inc., SignalFire and FJ Labs.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe